EMD – innovative, specialized, international
In North America, Merck, Darmstadt, Germany operates under the umbrella brand EMD, formed from the initials of Emanuel Merck,
Darmstadt. The EMD Group is a global pharmaceutical and chemical enterprise with approximately 40,000 employees in 66 countries.
With the acquisition of Millipore in July 2010, a global leader in the life science tools market, pro forma revenues for 2009
totaled around EUR 8.9 billion. The Pharmaceuticals business sector comprises innovative prescription drugs as well as over-the-counter
products. The Chemicals business sector offers specialty products for the electronics, printing, coatings, cosmetics, pharmaceutical
and biotech industries.
The operational business is managed under the umbrella of Merck KGaA headquartered in Darmstadt, Germany. Around 30% of the
company’s total capital is publicly traded, while the Merck family owns an interest of about 70% via the general partner E.
Merck OHG.
Merck in Darmstadt is the world’s oldest pharmaceutical and chemical company – its roots date back to 1668.
| The most important therapeutic / application areas of EMD products | |
| Pharmaceuticals | |
| EMD Serono: | Oncology, neurodegenerative diseases, fertility, endocrinology, autoimmune and inflammatory diseases, CardioMetabolic Care |
| Consumer Health Care: | Everyday health protection, mobility, women’s and children’s health, cough and cold |
| Chemicals | |
| EMD Millipore: | Protein research assays and reagents, cell culture solutions and drug discovery services for biopharmaceutical companies as well as laboratory chemicals for research, analytical and hospital laboratories |
| Performance Materials: | Liquid crystals for displays used in televisions, PCs and consumer electronics. LED and OLED materials for display, lighting, and photovoltaics as well as pigments for the cosmetics, paints and coatings industries |
